Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B

Philip Hampel, Kerstin Römermann, Nanna MacAulay, Wolfgang Löscher

12 Citations (Scopus)
50 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B'. Together they form a unique fingerprint.

Medicine & Life Sciences